2016 Value in Cancer Care Summit

Hutchinson Institute for Cancer Outcomes Research

2016 Value in Cancer Care Summit

Dr. Jennie Crews, left, speaks during the Breast Cancer Surveillance Working Group panel, alongside Working Group members: Dr. Patricia Dawson, Diane Mapes, and Courtney Preusse.

Photo by Robert Hood / Fred Hutch News Service

On April 1, 2016, HICOR convened its community stakeholders for the third annual VCC Summit at Bell Harbor International Conference Center. Participants provided feedback on three intervention proposals assembled by the VCC Working Groups and discussed the ethical implication of introducing value in the patient/provider relationship, and well as the costs of care.  Patients, clinicians, provider groups, patient advocacy groups, public and private payers, researchers, pharmaceutical professionals, and government and policy experts participated in these important conversations about cancer care delivery in our region.

The Hutch News Services article Collaborating to boost value-based care provides an overview of key discussion and findings shared at the summit. In addition, you can review the meeting materials below, which include summit handouts and the agenda.

Summaries of Working Groups and Summit


 8:00 a.m. -    8:30 a.m.  
Registration / Welcome Coffee

Opening and Keynote Address

 8:30 a.m. -    9:00 a.m. Opening Remarks, Scott Ramsey, MD, PhD / Gary Lyman, MD, MPH

 9:00 a.m. -  10:00 a.m. Keynote Address, Craig Earle, MD, MSc

Intervention Working Groups 

The 2016 Intervention Working Groups are comprised of diverse individuals dedicated to transforming critically important ideas into effective models for intervention in cancer care. Since the first VCC Summit in 2014, HICOR has engaged stakeholders to identify key areas of focus (2014) and prioritized the most important intervention ideas from our community (2015). Building on this momentum, HICOR launched the Intervention Working Groups to discuss how best to improve care in the following three areas: (1) End of life care for cancer patients, (2) Advanced imaging and tumor marker testing in breast cancer surveillance, and (3) Hospitalizations (inpatient and ED use) during cancer treatment. Each working group will present their discussions and recommendations at the 2016 Summit.
10:00 a.m. - 10:30 a.m.
Break and Poster Session
10:30 a.m. - 11:15 a.m.
Panel: End of Life Care
11:15 a.m. - 12:00 p.m.
Panel: Breast Cancer Surveillance
12:00 p.m. -   1:00 p.m.
  1:00 p.m. -   1:45 p.m.   Panel: Hospitalization During Treatment
  1:45 p.m. -   2:00 p.m.
Break and Poster Session

Bioethics and Patient Care

HICOR’s value metrics provide a regional view of oncology performance against accepted standards and guidelines, with the intent of identifying opportunities to improve care across a broad population.  But how can our data support individual patients and providers in decision-making?  This session will address bioethical implications of introducing value discussions into patient care.

  2:00 p.m. -  3:30 p.m.                          Bioethical Implications of Value and the Physician/Patient Relationship 

Keynote Speaker: Wylie Burke, MD, PhD

Panel Discussion: Patient and Physician   

  3:30 p.m. -   3:45 p.m. Break

Regional Cost Metrics

In this session, Dr. Scott Ramsey will introduce HICOR’s methodology for evaluating cost, and share regional cost metrics relevant to clinical scenarios discussed in the Intervention Working Groups.

  3:45 p.m. -   4:45 p.m.     
Regional Cost Metrics and HICOR IQ Update, Scott Ramsey, MD, PhD

  4:45 p.m. -   5:00 p.m. Closing Remarks, Gary Lyman, MD, MPH
  5:00 p.m. Poster Session and Reception